Equities closed higher with the Dow up 0.93% to 51,828.62 leading the tape, the S&P 500 adding 0.51% to 7,743.41 and the Nasdaq gaining 0.48%, while the Russell 2000's 0.07% nudge flagged listless small-cap participation. Industrials (+0.95%) led sectors, with Communication Services (-0.90%) and Energy (-0.89%) lagging. KOD doubled (+100.93%) as the day's top gainer while MDB fell 19.36% after Meta hired away its CEO. With the 10-year at 5.18% and oil rising, stock futures point lower to start the week (S&P -0.32%) and the VIX is up 7.73% at 16.02.
Change on the day for the major indices. VIX sits in the metric strip above — it reads inversely, so it is kept out of this scale.
Every bar opens the sector ETF's live page.
QL signal universe · click a bar for the live 5-factor read.
QL signal universe · click a bar for the live 5-factor read.
Across 4,696 counted names, 26.1% screen bullish (1,214 buy, 13 strong buy) versus 807 sell-side signals, and breadth narrowed 2.8 points from yesterday. Index gains on thinning breadth mean leadership is concentrating — fewer names are carrying the tape, so participation quality matters more than index level here. The 13-name strong-buy list skews to small caps (SILC, YDES, EAF) while the strong-sell cohort includes larger infrastructure and software names (UI, APPN).
Hover the line (or focus it and use ← →) to read any single session.
Strong Buy standouts: SILC · YDES · EAF · SRFM · LINK · NA · MIRA · EEIQ · SONM · TWAV · GRI · SXTP
Strong Sell standouts: UI · FIG · APPN · NKTR · TBN · ANRO · SEG · AARD · TRT · AIRT · DTCX · QXL
See full signals →| Ticker | Next Report | In | Last EPS YoY | Last Rev YoY |
|---|---|---|---|---|
| MSFT | 2026-10-26 | 28d | +31.8% | +17.7% |
| TSLA | 2026-11-16 | 48d | -3.0% | +25.5% |
| AAPL | 2026-11-23 | 56d | +28.7% | +16.4% |
| XOM | 2026-11-24 | 56d | +112.2% | +42.3% |
| JPM | 2026-11-30 | 63d | +46.9% | +27.7% |
| NVDA | 2026-12-17 | 80d | +127.8% | +105.9% |
Bar length = days until the report · green/red = last EPS YoY direction · click through to the live page.
Year-over-year movement
The primary catalyst is the IPO window: Oura (OURA) is dated for Sept. 30 with a $40-$44 range, after SOUD priced at $11 and FLSC at $10. The earnings calendar is quiet — the nearest mega-cap report is MSFT on Oct. 26, 28 days out.
| Ticker | Company | Listing Date | In | Offer Range | Exchange |
|---|---|---|---|---|---|
| OURA | Oura Inc. | 2026-09-30 | 2d | $40–$44 | XNAS |
| ACCV | Accelevation Holdings Corp. | 2026-09-30 | 2d | $20–$24 | XNAS |
| CTY | City Therapeutics Inc. | TBA | — | — | XNAS |
| SOUD | Hacker Interstellar Inc. | TBA | — | $11 | XNAS |
| FLSC | Frazier Life Sciences Acquisition Corp. II | TBA | — | $10 | XNAS |
| BYOP | KiNRG Inc. | TBA | — | $5–$7 | XASE |
| IVAI | Ives Ultra AI Opportunities Inc. | TBA | — | $10–$10 | XNYS |
| STNF | Santa Ana Global Enterprises S.A. | TBA | — | $13–$15 | XASE |
| FYH | Sprout Red International Ltd. | TBA | — | — | XNAS |
| IAM | Iambic Therapeutics Inc. | TBA | — | — | XNAS |
Listing-pipeline headlines
Full pipeline + S-1 tracker on IPO Radar · pre-IPO valuations and secondaries on Private Companies.
OpenEvidence's reported $250M raise at a $15B valuation anchors a busy private tape, alongside Rightway's $155M Series E at a $1.75B valuation led by Francisco Partners. Insight Partners leads on deal count (6, $336.6M) while UAE-affiliated entities top dollar deployment at $6B across 2 deals.
| Date | Company | Event | Amount | Lead Investor |
|---|---|---|---|---|
| 2026-09-26 | Sanyark Space · Space | Pre-Seed $2M led by Avaana Capital; AUM Ventures | $2M | Avaana Capital; AUM Ventures |
| 2026-09-25 | Arivihan · Education | Series A $10M led by Accel; Prosus | $10M | Accel; Prosus |
| 2026-09-24 | OpenEvidence · Healthcare | Unlabeled (reported) $250M | $250M | — |
| 2026-09-24 | HIFI · Fintech | Series A $37M led by Left Lane Capital | $37M | Left Lane Capital |
| 2026-09-24 | Rightway · Healthcare | Series E $155M led by Francisco Partners | $155M | Francisco Partners |
| 2026-09-24 | BigHat Biosciences · Drug Discovery | Series C $75M led by DFJ Growth; Premji Invest (co-leads) | $75M | DFJ Growth; Premji Invest (co-leads) |
| 2026-09-24 | Ando · Business/Productivity Software | Pre-seed + Seed (combined) $20M led by Index Ventures; Emergence Capital (seed); Accel (pr | $20M | Index Ventures; Emergence Capital (seed); Accel (pre-seed) |
| 2026-09-24 | Basalt Health · Healthcare | Series A $20M led by NEA | $20M | NEA |
Track 2,587 pre-IPO names on Private Companies · browse 280+ investor profiles · live deal tape on Deal Signals.
Bar = amount raised · click through to the company's pre-IPO page.
Where the money went — sector split
Most active lead investors (last 45 days)
Educational framework discussion of market conditions — not investment advice or a recommendation to buy or sell any security.
When an index rises while signal breadth narrows — today's S&P +0.51% against a 2.8-point drop in bullish share — the average stock is quietly underperforming the average headline. Narrow breadth means gains rest on fewer large weights, so the index grows more sensitive to any single holding's news, as MDB's 19.36% plunge illustrates. At a 5.18% 10-year yield, the opportunity cost of holding weak-participation names is elevated, which tends to accelerate rotation toward the leaders. The metric to track is whether bullish share stabilizes near 26% or keeps eroding: the former suggests consolidation, the latter a leadership regime that can reverse quickly.